Trials / Conditions / Stage IVB Cervical Cancer

Stage IVB Cervical Cancer

25 registered clinical trials studyying Stage IVB Cervical Cancer.

Status	Trial	Sponsor	Phase
Unknown	First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cance NCT04974944	Sun Yat-sen University	Phase 2
Completed	Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn NCT03112668	Rutgers, The State University of New Jersey	N/A
Completed	Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations NCT02646319	Mayo Clinic	EARLY_Phase 1
Completed	Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer NCT02164461	Advaxis, Inc.	Phase 1
Completed	Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe NCT01846520	City of Hope Medical Center	N/A
Completed	Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer NCT01676818	University of Southern California	Phase 2
Completed	Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Re NCT01266447	National Cancer Institute (NCI)	Phase 2
Completed	Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Pa NCT01098630	Gynecologic Oncology Group	—
Completed	Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258	University of Southern California	Phase 1
Completed	Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Can NCT01026792	National Cancer Institute (NCI)	Phase 2
Completed	Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer NCT00941070	National Cancer Institute (NCI)	Phase 2
Completed	Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan NCT01079832	Case Comprehensive Cancer Center	Phase 2
Completed	Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurre NCT00803062	National Cancer Institute (NCI)	Phase 3
Terminated	Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extr NCT00577317	Gynecologic Oncology Group	Phase 3
Completed	FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer NCT00559377	National Cancer Institute (NCI)	Phase 2
Completed	Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be NCT00389974	National Cancer Institute (NCI)	Phase 2
Completed	Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Witho NCT00335998	National Cancer Institute (NCI)	Phase 1
Completed	EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometria NCT00107445	National Cancer Institute (NCI)	Phase 2
Completed	Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recu NCT00064077	Gynecologic Oncology Group	Phase 3
Completed	Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer NCT00057863	National Cancer Institute (NCI)	Phase 2
Completed	Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction NCT00030498	National Cancer Institute (NCI)	Phase 1
Completed	7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid NCT00031681	National Cancer Institute (NCI)	Phase 1
Completed	Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074	National Cancer Institute (NCI)	Phase 1
Completed	Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442	Gynecologic Oncology Group	—
Withdrawn	Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or NCT01313104	Northwestern University	N/A